Showing results (1241-1250 of 1,902) with videos related to
Sort By:
Pageof 191
Healthcare (Basel, Switzerland)|August 26, 2023
Understanding Hearing Health: A Cross-Sectional Study of Determinants in a Metropolitan AreaFrancesca Pennino, Maddalena Di Lillo, Michele Sorrentino, et al.Genomics Insights|August 18, 2015
Design, Construction and Validation of Targeted BAC Array-Based CGH Test for Detecting the Most Commons Chromosomal AbnormalitiesStefano Gambardella, Erika Ciabattoni, Francesca Motta, et al.Inflammatory Bowel Diseases|June 6, 2022
David Against Goliath: Direct Comparison of Handheld Bowel Sonography and Magnetic Resonance Enterography for Diagnosis of Crohn's DiseaseAntonio Rispo, Roberto de Sire, Pier Paolo Mainenti, et al.La Radiologia Medica|December 5, 2021
Delta radiomics: a systematic reviewValerio Nardone, Alfonso Reginelli, Roberta Grassi, et al.Journal of Dental Research|May 22, 2013
Fluoride concentration from dental sealants: a randomized clinical trialG Campus, G Carta, M G Cagetti, et al.Biorxiv : the Preprint Server for Biology|June 9, 2023
3D Variability Analysis Reveals a Hidden Conformational Change Controlling Ammonia Transport in Human Asparagine SynthetaseAdriana Coricello, Alanya J Nardone, Antonio Lupia, et al.International Journal of Molecular Sciences|March 28, 2024
Treatment of Thoracic SMARCA4-Deficient Undifferentiated Tumors: Where We Are and Where We Will GoVito Longo, Annamaria Catino, Michele Montrone, et al.Journal of Clinical Medicine|June 27, 2024
The Efficacy of CO<sub>2</sub> Vaginal Laser in the Treatment of Recurrent, Post-Coital and Interstitial Cystitis: A Multicentric Prospective StudyDaniela Luvero, Adele Silvagni, Anna Maria Angioli, et al.Medical Oncology (Northwood, London, England)|April 10, 2020
Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacyMaria Paola Belfiore, Alfonso Reginelli, Nicola Maggialetti, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2010
Histopathologic and immunohistochemical characterization of rash to human epidermal growth factor receptor 1 (HER1) and HER1/2 inhibitors in cancer patientsBeatrice Nardone, Kimberly Nicholson, Marissa Newman, et al.Pageof 191